Merck, Sun Pharma secure legal victory as Indian court penalizes generic-patent infringer
Merck and Sun Pharma have secured a legal victory after an Indian court penalized patent infringement of Sitagliptin, reinforcing legal protections for pharmaceutical innovation against unauthorized generic manufacturing.Merck Sharp & Dohme...To view the full article, register now.
Already a subscriber? Click here to view full article